These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Folliculitis and mesalamine. Lizasoain J; Rubio FA; Erdozain JC; Olveira A; Conde P Am J Gastroenterol; 1996 Apr; 91(4):819-20. PubMed ID: 8677969 [No Abstract] [Full Text] [Related]
14. 5-Aminosalicylic acid in the treatment of inflammatory bowel disease. Bondesen S; Rasmussen SN; Rask-Madsen J; Nielsen OH; Lauritsen K; Binder V; Hansen SH; Hvidberg EF Acta Med Scand; 1987; 221(3):227-42. PubMed ID: 3296672 [No Abstract] [Full Text] [Related]
15. [Aminosalicylates in the treatment of chronic inflammatory bowel diseases]. Hartmann F; Plauth M Internist (Berl); 1990 Nov; 31(11):702-6. PubMed ID: 2289856 [No Abstract] [Full Text] [Related]
16. The short- and long-term safety of 5-aminosalicylate products in the treatment of ulcerative colitis. Baker DE; Kane S Rev Gastroenterol Disord; 2004; 4(2):86-91. PubMed ID: 15185719 [TBL] [Abstract][Full Text] [Related]
17. [Ulcerative colitis and pericarditis. The role of mesalazine hypersensitivity]. Loizeau E Rev Med Suisse Romande; 1995 Nov; 115(11):935-8. PubMed ID: 8525252 [No Abstract] [Full Text] [Related]
18. Pleuropericarditis in a patient with ulcerative colitis in longstanding 5-aminosalicylic acid therapy. Iaquinto G; Sorrentini I; Petillo FE; Berardesca G Ital J Gastroenterol; 1994 Apr; 26(3):145-7. PubMed ID: 8061342 [TBL] [Abstract][Full Text] [Related]
19. Use of mesalamine and olsalazine in ulcerative colitis. Gait JE; Powell JH; Regalli G Am Fam Physician; 1993 Nov; 48(7):1234, 1236. PubMed ID: 8237737 [No Abstract] [Full Text] [Related]